comparemela.com

Page 55 - Idiopathic Pulmonary Fibrosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosis

In a new study, researchers identified distinguishing immune features of coronavirus disease 2019 (COVID-19) in patients with late-resolving pulmonary fibrosis (LR COVID-PF) and early-resolving (ER COVID-PF).

Aimee molineuxNeha mathurNeha mathuroctIdiopathic pulmonary fibrosisCoronavirus disease covid 19Covid 19Pulmonary fibrosisEne expression

Primary Care Doctors Knowledge of IPF Could Speed Up Diagnoses

Prompt diagnosis of idiopathic pulmonary fibrosis is essential to reduce mortality, and improving education of primary care providers can help.

Krishna thavarajahDanielf dillingLoyola university chicagoClinical perspectivesFactors driving diagnostic delaysIdiopathic pulmonaryDifferential diagnosisPatients with shortnessHenry ford hospitalIdiopathic pulmonary fibrosisLung fibrosisPulmonary fibrosisIbrosis pulmonaryMedical educationInterstitial lung diseasePatient care management

New screening tool accurately identifies patients at high risk of idiopathic pulmonary fibrosis

A new screening tool for electronic medical records accurately identifies patients who are at high risk of having or developing progressive scarring of the lungs, a condition called idiopathic pulmonary fibrosis, according to investigators from Weill Cornell Medicine, NewYork-Presbyterian, the University of Chicago, Brigham and Women's Hospital and Mayo Clinic.

United statesWeill cornellFernando martinezIshanu chattopadhyayGary matt hunninghakeEmily hendersonDivision of pulmonaryInterstitial lung disease program at brighamPresbyterian weill cornell medical centerStudy coUniversity of chicagoWeill cornell medicineNature medicineBruce webster professorInternal medicineCritical care medicine

LncDACH1 may be a potential therapeutic target for pulmonary fibrosis

This new article publication from Acta Pharmaceutica Sinica B, discusses how LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation.

Acta pharmaceutica sinicaEmily hendersonPulmonary fibrosisIdiopathic pulmonary fibrosis

Nuformix PLC showcases proprietary tranilast programme to potential licensing partners

Nuformix PLC showcases proprietary tranilast programme to potential licensing partners
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaDan goodingEuropean respiratory societyIdiopathic pulmonary fibrosis

vimarsana © 2020. All Rights Reserved.